Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
Reference65 articles.
1. A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer - Full Text View - ClinicalTrials.gov [Internet]. [cited 2023 Aug 24]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT05361174.
2. Clink, a nanovirus-encoded protein, binds both pRB and SKP1;Aronson;J. Virol.,2000
3. Asmamaw Dejenie T., Tiruneh G/Medhin M., Dessie Terefe G., Tadele Admasu F., Wale Tesega W., Chekol Abebe E.. Current updates on generations, approvals, and clinical trials of CAR T-cell therapy. Hum Vaccines Immunother. 18(6):2114254.
4. Tumor-infiltrating lymphocytes in colorectal cancer: the fundamental indication and application on immunotherapy;Bai;Front Immunol.,2022
5. A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma;Budczies;Oncoimmunology,2021